T 1259/16 (Glatiramer acetate III/TEVA) of 12.9.2017

European Case Law Identifier: ECLI:EP:BA:2017:T125916.20170912
Date of decision: 12 September 2017
Case number: T 1259/16
Application number: 10194363.7
IPC class: C07K 1/00
C07K 1/14
C07K 14/00
C08G 69/10
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 569 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Process for the preparation of mixtures of trifluoroacetyl glatiramer acetate using purified hydrobromic acid
Applicant name: Teva Pharmaceutical Industries Ltd.
Opponent name: Generics [UK] Ltd (trading as Mylan)
Actavis Group ehf (opposition withdrawn)
Synthon BV
Hexal AG
G. L. Pharma GmbH (Intervener)
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 105
European Patent Convention Art 114(2)
European Patent Convention Art 123(2)
Rules of procedure of the Boards of Appeal Art 13(1)
Keywords: Main request, auxiliary requests 1 to 32: amendments - allowable (no)
Auxiliary requests 33 to 35: admitted (no)
Catchwords:

-

Cited decisions:
G 0002/10
T 0686/99
T 0727/00
T 1241/03
T 0783/09
T 1649/10
T 2134/10
T 1581/12
T 1536/14
Citing decisions:
-

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t161259eu1.html

Date retrieved: 17 May 2021

13 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: II Conditions to be met by an Application

Case Law of the Enlarged Board

General Case Law